Lipoprotein(a)—also known as Lp(a)—is becoming an emerging marker of cardiovascular risk, generating increasing interest among researchers and healthcare professionals. Its more frequent inclusion in clinical practice guidelines reinforces the need to update knowledge about its epidemiology, its interpretation in practice, and treatment prospects.
With that objective, the Institute for Clinical and Health Effectiveness (IECS) is organizing the webinar “Present and future of Lipoprotein (a) in cardiovascular health”, which will offer a comprehensive look at the present and future of Lp(a) in cardiovascular health.
For one hour, specialists from various institutions will share the latest scientific advances and clinical challenges related to this biomarker. The event is free, virtual (via Zoom), and requires prior registration.
Programme
18:00 – 18:05 h | Welcome
18:05 – 18:20 h | What do we know about the epidemiology of lipoprotein(a)?
Dr. Pablo Gulayin (Department of Chronic Disease Research, IECS)
18:20 – 18:35 h | Lp(a) today: assessment, interpretation and application in clinical practice
Dr. Matías Arrupe (Argentine Federation of Cardiology)
18:35 – 18:50 h | Advances and future in the treatment of elevated Lp(a)
Dr. Alfredo Lozada (FLENI)
18:50 – 19:00 h | Questions and comments
Sign up at https://zoom.us/webinar/register/WN_XAhW7vKqSj-gETkiqsDNeA#/registration